[HTML][HTML] Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence …

N Wu, K Joyal-Desmarais, PAB Ribeiro… - The Lancet …, 2023 - thelancet.com
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …

[HTML][HTML] Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis

S Xu, J Li, H Wang, F Wang, Z Yin, Z Wang - BMC medicine, 2023 - Springer
Background The two inactivated SARS-CoV-2 vaccines, CoronaVac and BBIBP-CorV, have
been widely used to control the COVID-19 pandemic. The influence of multiple factors on …

Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and …

X Zhang, J Xia, L Jin, Y Wu, X Zheng… - Human Vaccines & …, 2023 - Taylor & Francis
We aimed to evaluate the effectiveness or efficacy of heterologous or homologous COVID-
19 vaccine regimens against COVID-19-related outcomes after primary immunization with …

[HTML][HTML] Real-world effectiveness of COVID-19 vaccines against severe outcomes during the period of Omicron predominance in Thailand: a test-negative nationwide …

N Nittayasoot, R Suphanchaimat, P Thammawijaya… - Vaccines, 2022 - mdpi.com
Due to the widespread Omicron variant of SARS-CoV-2 in Thailand, the effectiveness of
COVID-19 vaccines has become a major issue. The primary objective of this study is to …

[HTML][HTML] Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against …

S Niyomnaitham, A Jongkaewwattana… - International Journal of …, 2023 - Elsevier
Objectives The study aimed to compare the immunogenicity and safety of fractional (half)
third doses of heterologous COVID-19 vaccines (AZD1222 or BNT162b2) to full doses after …

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

C Chayachinda, K Watananirun… - Human Vaccines & …, 2023 - Taylor & Francis
This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of
heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women …

[HTML][HTML] Protective effect of inactivated COVID-19 vaccines against omicron BA. 2 infection in guangzhou: A test-negative case-control real-world study

D Zhang, J Zhong, H Xiong, Y Li, T Guo, B Peng… - Vaccines, 2023 - mdpi.com
This study aims to explore the relationship between the doses of inactivated COVID-19
vaccines received and SARS-CoV-2 Omicron infection in the real-world setting, so as to …

[HTML][HTML] Learning from pandemic responses: informing a resilient and equitable health system recovery in Thailand

V Tangcharoensathien, J Vandelaer, R Brown… - Frontiers in public …, 2023 - frontiersin.org
This article is part of the Research Topic 'Health Systems Recovery in the Context of COVID-
19 and Protracted Conflict'. The third quarter of 2022 saw COVID-19 cases and deaths in …

[HTML][HTML] Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: A prospective cohort study

M Wichaidit, T Nopsopon, K Sunan… - The Lancet Regional …, 2023 - thelancet.com
Background Several COVID-19 vaccination rollout strategies are implemented. Real-world
data from the large-scale, government-mandated Central Vaccination Center (CVC) …

[HTML][HTML] Cost-effectiveness analysis of COVID-19 vaccine booster dose in the Thai setting during the period of Omicron variant predominance

K Sirison, N Nittayasoot, R Techasuwanna… - Tropical Medicine and …, 2023 - mdpi.com
The Thai government implemented COVID-19 booster vaccines to prevent morbidity and
mortality during the spreading of the Omicron variant. However, little is known about which …